InvestLog
MGNX logo

MGNX

MacroGenics, Inc.NASDAQHealthcare
$3.07+5.86%ClosedMarket Cap: $195.1M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-10Barclays—Overweight—
2025-11-03HC Wainwright & Co.—Neutral—
2025-08-15Leerink Partners—Outperform—
2025-05-20B. Riley Securities—Neutral—
2025-05-14Barclays—Overweight—
2025-05-14Stifel—Hold—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-1.59$98.6M2
Sun Dec 31$-2.48$113.5M2
Mon Dec 31$-2.20$120.5M1
Tue Dec 31$-1.63$153.1M1